ALT Long Call Strategy
ALT (Altimmune, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Altimmune, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for obesity and various liver diseases. Its primary investigational drug, pemvidutide (proposed INN, previously known as ALT-801), operates as a GLP-1/glucagon dual receptor agonist. This compound is currently undergoing Phase 1b clinical trials, exploring its efficacy in treating both obesity and non-alcoholic steatohepatitis (NASH). Additionally, Altimmune is advancing HepTcell, an immunotherapeutic candidate, through Phase 2 clinical trials. This therapy is designed for individuals suffering from chronic hepatitis B virus infection. The enterprise, initially named Vaxin Inc., officially adopted the Altimmune, Inc. moniker in September 2015.
ALT (Altimmune, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $571.8M, a beta of 0.17 versus the broader market, a 52-week range of 2.56-6.44, average daily share volume of 4.3M, a public-listing history dating back to 2017, approximately 57 full-time employees. These structural characteristics shape how ALT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.17 indicates ALT has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. ALT pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a long call on ALT?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
ALT snapshot
As of August 14, 2026, spot at $2.92, ATM IV 152.62%, IV rank 35.97%, expected move 19.41%. The long call on ALT below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.
Why this long call structure on ALT specifically: ALT IV at 152.62% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 19.41% (roughly $0.57 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ALT expiries trade a higher absolute premium for lower per-day decay. Position sizing on ALT should anchor to the underlying notional of $2.92 per share and to the trader's directional view on ALT stock.
ALT long call setup
The ALT long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ALT at $2.92 on that close, the first option leg uses a $2.92 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ALT chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ALT shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $2.92 | N/A |
ALT long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
ALT long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on ALT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on ALT
Long calls on ALT express a bullish thesis with defined risk; traders use them ahead of ALT catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
ALT thesis for this long call
The market-implied 1-standard-deviation range for ALT extends from approximately $2.35 on the downside to $3.49 on the upside. A ALT long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current ALT IV rank near 35.97% is mid-range against its 1-year distribution, so the IV signal is neutral; the long call thesis on ALT should anchor more to the directional view and the expected-move geometry. As a Healthcare name, ALT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ALT-specific events.
ALT long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ALT positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ALT alongside the broader basket even when ALT-specific fundamentals are unchanged. Long-premium structures like a long call on ALT are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ALT chain quotes before placing a trade.
Frequently asked questions
- What is a long call on ALT?
- A long call on ALT is the long call strategy applied to ALT (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With ALT stock at $2.92 on the most recent close, the strikes shown on this page are snapped to the nearest listed ALT chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are ALT long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the ALT long call priced from the end-of-day chain at a 30-day expiry (ATM IV 152.62%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ALT long call?
- The breakeven for the ALT long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The ALT market-implied 1-standard-deviation expected move in the same options snapshot is approximately 19.41%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on ALT?
- Long calls on ALT express a bullish thesis with defined risk; traders use them ahead of ALT catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current ALT implied volatility affect this long call?
- ALT ATM IV is at 152.62% with IV rank near 35.97%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.